LAVAL Quebec Sept. 6 2016 PRNewswire &160;Valeant Pharmaceuticals International Inc. NYSE VRX and TSX VRX "Valeant" and Progenics Pharmaceuticals Inc. Nasdaq PGNX "Progenics" today announced the U.S. commercial launch of RELISTOR&am...
↧